| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Internal Medicine, Pulmonary and Critical Care Medicine Division, University of Michigan Health Sciences Center, Ann Arbor, Michigan
Mice with homozygous deletion of the plasminogen activator inhibitor-1 gene (PAI-1-/-) are relatively protected from bleomycin-induced pulmonary fibrosis. At least part of the protective effect appears to occur during the latter stages of the pathological process when fibrotic tissue is being deposited. To investigate the effect of PAI-1 deficiency on fibrosis, we studied the accumulation of fibrotic tissue within subcutaneously implanted polyvinyl alcohol sponges. Similar to the effect of PAI-1 deficiency on bleomycin-induced pulmonary fibrosis, the accumulation of fibrotic tissue within implanted sponges occurred more slowly in PAI-1-/- compared to wild-type mice. Another striking difference observed in the PAI-1-/- mice was the rapid removal of a fibrin-rich matrix that formed within the sponges by 1 day after implantation in both wild-type and PAI-1-/- mice. The pattern of connective tissue invasion also differed: cells in wild-type mice infiltrated as individually penetrating cells whereas in PAI-1-/- mice they did so as a well-demarcated advancing front. Providing an alternative provisional matrix by impregnating sponges with a low concentration of collagen before implantation corrected the changes induced by PAI-1 deficiency. In conclusion, PAI-1 deficiency appears to affect fibrotic tissue formation in part by altering the provisional matrix that forms soon after tissue injury.
This article has been cited by other articles:
 |
|
 |
|
  Z. Xu, F. J. Castellino, and V. A. Ploplis Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture Blood, March 11, 2010; 115(10): 2038 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fabre, J. Marchal-Somme, S. Marchand-Adam, C. Quesnel, R. Borie, M. Dehoux, C. Ruffie, J. Callebert, J-M. Launay, D. Henin, et al. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice Eur. Respir. J., August 1, 2008; 32(2): 426 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fujimoto, E. C. Gabazza, O. Taguchi, Y. Nishii, H. Nakahara, N. E. Bruno, C. N. D'Alessandro-Gabazza, M. Kasper, Y. Yano, M. Nagashima, et al. Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis Am. J. Pathol., April 1, 2006; 168(4): 1086 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Vayalil, M. Olman, J. E. Murphy-Ullrich, E. M. Postlethwait, and R.-M. Liu Glutathione restores collagen degradation in TGF-{beta}-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L937 - L945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hageman, B. J. Eggen, T. Rozema, K. Damman, H. H. Kampinga, and R. P. Coppes Radiation and Transforming Growth Factor-{beta} Cooperate in Transcriptional Activation of the Profibrotic Plasminogen Activator Inhibitor-1 Gene Clin. Cancer Res., August 15, 2005; 11(16): 5956 - 5964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice J. Immunol., August 1, 2005; 175(3): 1937 - 1946. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
